Edwardson, Matthew A.
Mitsuhashi, Masato
Van Epps, Dennis
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (1U10NS086513)
National Center for Advancing Translational Sciences (KL2TR001432)
Article History
Received: 3 October 2023
Accepted: 29 February 2024
First Online: 4 March 2024
Competing interests
: The study sponsor, NanoSomiX, Inc., provided support in the form of salaries for authors D.V. and M.M., and half the funding to isolate and quantify EV populations from plasma samples, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. NanoSomiX holds issued US and International pending patents on the methods for capture and analysis of plasma EVs used in this study. Georgetown University and NanoSomiX, Inc. have a collaborative agreement in place and have filed a provisional patent related to the use of brain-derived EVs in the care and diagnosis of stroke patients with M.A.E, M.M. and D.V. named as inventors. M.A.E. declares no other competing interests. This work was supported by internal funds from Georgetown University (M.A.E.) and support to analyze plasma samples was provided by NanoSomiX, Inc.